FDA Adverse Event Death Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 3503932 · Received December 6, 2013

Report

Report Number
2024168-2013-07824
Event Type
Death
Date Received
December 6, 2013
Date of Event
October 11, 2013
Report Date
November 11, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE STENT REMAINS IN THE PATIENT. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW UP REPORT WILL BE SUBMITTED WITH ALL RELEVANT INFORMATION. YOU ARE RECEIVING THIS MDR REPORT FROM ABBOTT VASCULAR BECAUSE BOSTON SCIENTIFIC CORPORATION DISTRIBUTES PROMUS AS ITS OWN BRAND LABELING OF ABBOTT VASCULARS DRUG ELUTING STENT IN THE US.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS NOT POSSIBLE TO PERFORM AN ANALYSIS ON THE PRODUCT BECAUSE IT WAS NOT RETURNED TO ABBOTT VASCULAR FOR INVESTIGATION. HOWEVER, THERE WERE NO REPORTED DEVICE MALFUNCTION OR PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECT OF DEATH IS LISTED IN THE PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE IF ANY CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD AN UNSPECIFIED PROMUS STENT IMPLANTED ON (B)(6) 2011. ON (B)(6) 2013, 941 DAYS POST INDEX PROCEDURE, THE PATIENT DIED OF AN UNSPECIFIED CAUSE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
633389 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 53 YR Death